+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Endoscope Reprocessing Market Size, Share & Trends Analysis Report By End-use, By Product, By Automated Endoscope Reprocessors (AERs) Type, By Automated Endoscope Reprocessors (AERs) Portability, By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 97 Pages
  • August 2024
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5992274
The Latin America, Middle East and Africa Endoscope Reprocessing Market would witness market growth of 11.4% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Endoscope Reprocessing Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $56.9 million by 2031. The Argentina market is showcasing a CAGR of 12.3% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 11.1% during (2024 - 2031).



Insurance and reimbursement policies significantly impact the demand for endoscopic procedures and, consequently, the need for reprocessing equipment and consumables. Countries have varying policies that can influence the adoption of endoscopic procedures.

Moreover, in the United States, the Centers for Medicare and Medicaid Services (CMS) sets reimbursement rates for healthcare services, including endoscopic procedures. Favourable reimbursement rates can encourage healthcare providers to offer more endoscopic procedures, leading to a higher demand for reprocessing equipment and consumables.

Increasing rates of lifestyle-related illnesses, including diabetes and obesity, have contributed to a surge in endoscopic bariatric procedures throughout the Middle East. The prevalence of diabetes in the Middle East and North Africa (MENA) Region is 16.2%, which is the highest prevalence in any region, according to the International Diabetes Federation (IDF). The IDF also stated that the MENA Region has the second-highest expected increase (86%) in individuals with diabetes by 2045, reaching 136 million.

Based on End-use, the market is segmented into Outpatient Facilities and Hospitals. Based on Product, the market is segmented into High-level Disinfectants & Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AERs), Endoscope Drying, Storage, & Transport Systems and Others. Based on Automated Endoscope Reprocessors (AERs) Type, the market is segmented into Single Basin and Double Basin. Based on Automated Endoscope Reprocessors (AERs) Portability, the market is segmented into Standalone AER and Portable AER. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Belimed AG (Metall Zug AG)
  • ASP Global Manufacturing GmbH (FORTIVE CORPORATION)
  • Ecolab, Inc.
  • Getinge AB
  • Steelco S.p.A. (Miele Group)
  • ARC Healthcare Solutions Inc.
  • Metrex Research, LLC (Envista Holdings Corporation)
  • Shinva Medical Instrument Co., Ltd.

Market Report Segmentation

By End-use
  • Outpatient Facilities
  • Hospitals
By Product
  • High-level Disinfectants & Test Strips
  • Detergents & Wipes
  • Automated Endoscope Reprocessors (AERs)
  • Type
  • Single Basin
  • Double Basin
  • Portability
  • Standalone AER
  • Portable AER
  • Endoscope Drying, Storage, & Transport Systems
  • Others
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Endoscope Reprocessing Market, by End-use
1.4.2 LAMEA Endoscope Reprocessing Market, by Product
1.4.3 LAMEA Endoscope Reprocessing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. LAMEA Endoscope Reprocessing Market by End-use
4.1 LAMEA Outpatient Facilities Market by Country
4.2 LAMEA Hospitals Market by Country
Chapter 5. LAMEA Endoscope Reprocessing Market by Product
5.1 LAMEA High-level Disinfectants & Test Strips Market by Country
5.2 LAMEA Detergents & Wipes Market by Country
5.3 LAMEA Automated Endoscope Reprocessors (AERs) Market by Country
5.4 LAMEA Endoscope Reprocessing Market by Automated Endoscope Reprocessors (AERs) Type
5.4.1 LAMEA Single Basin Market by Country
5.4.2 LAMEA Double Basin Market by Country
5.5 LAMEA Endoscope Reprocessing Market by Automated Endoscope Reprocessors (AERs) Portability
5.5.1 LAMEA Standalone AER Market by Country
5.5.2 LAMEA Portable AER Market by Country
5.6 LAMEA Endoscope Drying, Storage, & Transport Systems Market by Country
5.7 LAMEA Others Market by Country
Chapter 6. LAMEA Endoscope Reprocessing Market by Country
6.1 Brazil Endoscope Reprocessing Market
6.1.1 Brazil Endoscope Reprocessing Market by End-use
6.1.2 Brazil Endoscope Reprocessing Market by Product
6.1.2.1 Brazil Endoscope Reprocessing Market by Automated Endoscope Reprocessors (AERs) Type
6.1.2.2 Brazil Endoscope Reprocessing Market by Automated Endoscope Reprocessors (AERs) Portability
6.2 Argentina Endoscope Reprocessing Market
6.2.1 Argentina Endoscope Reprocessing Market by End-use
6.2.2 Argentina Endoscope Reprocessing Market by Product
6.2.2.1 Argentina Endoscope Reprocessing Market by Automated Endoscope Reprocessors (AERs) Type
6.2.2.2 Argentina Endoscope Reprocessing Market by Automated Endoscope Reprocessors (AERs) Portability
6.3 UAE Endoscope Reprocessing Market
6.3.1 UAE Endoscope Reprocessing Market by End-use
6.3.2 UAE Endoscope Reprocessing Market by Product
6.3.2.1 UAE Endoscope Reprocessing Market by Automated Endoscope Reprocessors (AERs) Type
6.3.2.2 UAE Endoscope Reprocessing Market by Automated Endoscope Reprocessors (AERs) Portability
6.4 Saudi Arabia Endoscope Reprocessing Market
6.4.1 Saudi Arabia Endoscope Reprocessing Market by End-use
6.4.2 Saudi Arabia Endoscope Reprocessing Market by Product
6.4.2.1 Saudi Arabia Endoscope Reprocessing Market by Automated Endoscope Reprocessors (AERs) Type
6.4.2.2 Saudi Arabia Endoscope Reprocessing Market by Automated Endoscope Reprocessors (AERs) Portability
6.5 South Africa Endoscope Reprocessing Market
6.5.1 South Africa Endoscope Reprocessing Market by End-use
6.5.2 South Africa Endoscope Reprocessing Market by Product
6.5.2.1 South Africa Endoscope Reprocessing Market by Automated Endoscope Reprocessors (AERs) Type
6.5.2.2 South Africa Endoscope Reprocessing Market by Automated Endoscope Reprocessors (AERs) Portability
6.6 Nigeria Endoscope Reprocessing Market
6.6.1 Nigeria Endoscope Reprocessing Market by End-use
6.6.2 Nigeria Endoscope Reprocessing Market by Product
6.6.2.1 Nigeria Endoscope Reprocessing Market by Automated Endoscope Reprocessors (AERs) Type
6.6.2.2 Nigeria Endoscope Reprocessing Market by Automated Endoscope Reprocessors (AERs) Portability
6.7 Rest of LAMEA Endoscope Reprocessing Market
6.7.1 Rest of LAMEA Endoscope Reprocessing Market by End-use
6.7.2 Rest of LAMEA Endoscope Reprocessing Market by Product
6.7.2.1 Rest of LAMEA Endoscope Reprocessing Market by Automated Endoscope Reprocessors (AERs) Type
6.7.2.2 Rest of LAMEA Endoscope Reprocessing Market by Automated Endoscope Reprocessors (AERs) Portability
Chapter 7. Company Profiles
7.1 Belimed AG (Metall Zug AG)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Research & Development Expenses
7.2 ASP Global Manufacturing GmbH (Fortive Corporation)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Research & Development Expenses
7.3 ARC Healthcare Solutions Inc.
7.3.1 Company Overview
7.4 Metrex Research, LLC (Envista Holdings Corporation)
7.4.1 Company Overview
7.5 Shinva Medical Instrument Co., Ltd.
7.5.1 Company Overview
7.6 Ecolab, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Getinge AB
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 SWOT Analysis
7.8 Steelco S.p.A. (Miele Group)
7.8.1 Company Overview

Companies Mentioned

  • Belimed AG (Metall Zug AG)
  • ASP Global Manufacturing GmbH (FORTIVE CORPORATION)
  • Ecolab, Inc.
  • Getinge AB
  • Steelco S.p.A. (Miele Group)
  • ARC Healthcare Solutions Inc.
  • Metrex Research, LLC (Envista Holdings Corporation)
  • Shinva Medical Instrument Co., Ltd.

Methodology

Loading
LOADING...